AF is a non-entity, unimportant, a small fish. Why does anyone really cares about what he thinks. He is a minor leaguer trying to break into the majors. The reality is that he will be riding buses the rest of his career.
Steady climb on low volume and then volume really picked up the middle 2 hours of trading day. A very unusual pattern, especially in the absence of any news. Congrats to those who picked up shares under $6.75--I don't see this falling to those levels unless there is a major sell-off in biotech.
It's now been 18 months since the Roche deal was announced in Sep. 2013 and INO peaked near $12
post-split. A long ways to go to get back to those levels.
I do believe that Inovio delivers significant news by mid-March. It may not be the type of news that runs
the stock but could help it get back to $10 levels.